Evidence map›Paper›PMID 32992741›Full record

ReviewInternational journal of molecular sciences2020

Exosomes: Insights from Retinoblastoma and Other Eye Cancers.

Kashmiri Lande, Jitesh Gupta, Ravi Ranjan, Manjari Kiran, Luis Fernando Torres Solis, Arturo Solís Herrera, Gjumrakch Aliev, Roy Karnati

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke.Frontiers in bioengineering and biotechnology · 2022
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. MicroRNAs in the Mouse Developing Retina.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Exosomal targeting and its potential clinical application.Drug delivery and translational research · 2022
    Review
  18. Exosomes in Cancer Diagnosis and Therapy.International journal of molecular sciences · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Kashmiri LandeDepartment of Animal Biology, University of Hyderabad, Hyderabad 500046, India.
Jitesh GuptaDepartment of Animal Biology, University of Hyderabad, Hyderabad 500046, India.ORCID 0000-0001-6254-6154
Ravi RanjanDepartment of Animal Biology, University of Hyderabad, Hyderabad 500046, India.ORCID 0000-0002-5735-0832
Manjari KiranDepartment of Systems and Computational Biology, University of Hyderabad, Hyderabad 500046, India.ORCID 0000-0003-0153-7072
Luis Fernando Torres SolisThe School of Medicine, Universidad Autónoma de Aguascalientes, Aguascalientes 20392, Mexico.
Arturo Solís HerreraHuman Photosynthesis© Research Centre, Aguascalientes 20000, Mexico.
Gjumrakch AlievI.M. Sechenov First Moscow State Medical University (Sechenov University), St. Trubetskaya, 8, bld. 2, 119991 Moscow, Russia.ORCID 0000-0001-7373-3182
Roy KarnatiDepartment of Animal Biology, University of Hyderabad, Hyderabad 500046, India.
University of Hyderabad · INAutonomous University of Aguascalientes · MXSechenov University · RU

Funding

GALLY International Research Institute, San Antonio, Texas, USA ResearchGovernment of India and from Indian Council of Medical Research (ICMR) ISRM/12(45)/2019Govt. of India and from University Grants Commission (UGC), Govt. of India F.30-480/2019-BSRHuman Photosynthesis Study Center, Aguascalientes, México ResearchRRK by CSIR-JRF UoH research fellowshipRussian Academic Excellence project "5-100" for the Sechenov University, Moscow, RussiaScience and Engineering research Board (SERB) SRG/2019/001450
6 · The paper itself

Abstract

Exosomes, considered as cell debris or garbage bags, have been later characterized as nanometer-sized extracellular double-membrane lipid bilayer bio-vesicles secreted by the fusion of vesicular bodies with the plasma membrane. The constituents and the rate of exosomes formation differ in different pathophysiological conditions. Exosomes are also observed and studied in different parts of the eye, like the retina, cornea, aqueous, and vitreous humor. Tear fluid consists of exosomes that are shown to regulate various cellular processes. The role of exosomes in eye cancers, especially retinoblastoma (RB), is not well explored, although few studies point towards their presence. Retinoblastoma is an intraocular tumor that constitutes 3% of cases of cancer in children. Diagnosis of RB may require invasive procedures, which might lead to the spread of the disease to other parts. Due to this reason, better ways of diagnosis are being explored. Studies on the exosomes in RB tumors and serum might help designing better diagnostic approaches for RB. In this article, we reviewed studies on exosomes in the eye, with a special emphasis on RB. We also reviewed miRNAs expressed in RB tumor, serum, and cell lines and analyzed the targets of these miRNAs from the proteins identified in the RB tumor exosomes. hsa-miR-494 and hsa-miR-9, upregulated and downregulated, respectively in RB, have the maximum number of targets. Although oppositely regulated, they share the same targets in the proteins identified in RB tumor exosomes. Overall this review provides the up-to-date progress in the area of eye exosome research, with an emphasis on RB.

Indexed as

Retinal NeoplasmsRetinoblastomaCell LineExosomesEye NeoplasmsGene Expression Regulation, NeoplasticHumansMicroRNAsRetinaMicroRNAscorneaexosomesmiRNAretinoblastomatearsuveal melanoma

Identifiers

PMID32992741
PMCPMC7582726
OpenAlexW3088595477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.